1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

DEA has kratom users holding their breath, lawmakers write more letters

By Beenthere2Hippie, Oct 2, 2016 | |
  1. Beenthere2Hippie
    Starting today, the US Drug Enforcement Administration is free to list a popular herbal supplement called kratom as a Schedule I controlled substance. This would put kratom in the same lineup as heroin and make its sale and use a felony. But, in statements to the press, the agency said it has no timetable for officially listing kratom—it could be next week or longer—leaving users on the edge of their seats.

    Since the DEA announced (*1) its plan to ban kratom at the end of last month, thousands of users have frantically sought to reverse the decision, as well as buy up as much of the drug as they can. Users claim kratom, or Mitragyna speciosa, a tree in the coffee family, is effective at treating chronic pain, as well as depression, anxiety, PTSD, and other ailments.

    The main active ingredients in kratom are mitragynine and 7-hydroxymitragynine, which can interact with opioid receptors in the brain. While the data to back up medical use of the plant is scant, users are adamant that it's a lifesaver, allowing them to kick deadly and all-too-common opioid addictions.

    Since late August, more than 140,000 people have signed a petition asking the Obama administration to keep the DEA from banning kratom. On September 13, hundreds marched in front of the White House, hoisting signs that read “Kratom Saved Me” and sharing personal stories of how the drug got them off of opioid pain killers.

    Their efforts got the attention of lawmakers. Last week, 50 members of the House of Representatives (*2) signed a letter sent to the DEA urging the agency to delay listing kratom as a Schedule I until it can collect more information from the public and researchers.

    The letter, spearheaded by Mark Pocan (D-Wis.) and Matt Salmon (R-Ariz.), cites ongoing research into the use of kratom as a treatment for opioid withdrawal. “The DEA’s decision to place Kratom as a Schedule I substance will put a halt on federally funded research and innovation surrounding the treatment of individuals suffering from opioid and other addictions—a significant public health threat,” the letter reads. Any such listing of a potentially useful drug should not be done in haste, lawmakers argue.

    Now a similar letter, written by Senator Orrin Hatch (R-Utah) is circulating through the Senate, gathering signatures.

    Part of Congress’ objection to the DEA’s ban is the way the agency went about it. Usually, listing a drug involves a lengthy review, with input from the Food and Drug Administration and the public. But in this case, the agency made an emergency, unilateral decision based on the view that kratom presents a “public health crisis.”

    The emergency action means the DEA can temporarily add kratom to its list of Schedule I drugs. And in two or three years, that temporary listing can become permanent. The agency based its emergency action on the increasing importation of kratom, as well as the drug’s opioid-like effects and addictiveness. According to the DEA, US poison control centers received 660 calls about kratom use between 2010 and 2015.

    But lawmakers, users, and some scientists question the DEA’s claim that kratom is a critical threat. They point to anecdotal information that it’s helping people get off of opioids. Critics also note that US poison control centers receive millions of calls, often dealing with laundry detergent and prescription drugs.

    Editor's Note: This post was updated to correct the time frame of the 660 poison center calls.

    By Beth Mole - Arstechnica/Sept. 30, 2016
    Photo: Joe Raedle, getty
    Newshawk Crew

    Attached Chrome Extension pdfs______________

    (*1) DEA Kratom ban letter

    (*2) Letter to Shaun Donovan

    Author Bio

    BT2H is a retired news editor and writer from the NYC area who, for health reasons, retired to a southern US state early, and where BT2H continues to write and to post drug-related news to DF.


To make a comment simply sign up and become a member!